Works matching AU Czuczman, Myron S

Results: 54
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Radiation for diffuse large B-cell lymphoma in the rituximab era: Analysis of the National Comprehensive Cancer Network lymphoma outcomes project.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 7, p. 1032, doi. 10.1002/cncr.29113
    By:
    • Dabaja, Bouthaina S.;
    • Vanderplas, Ann M.;
    • Crosby‐Thompson, Allison L.;
    • Abel, Gregory A.;
    • Czuczman, Myron S.;
    • Friedberg, Jonathan W.;
    • Gordon, Leo I.;
    • Kaminski, Mark;
    • Niland, Joyce;
    • Millenson, Michael;
    • Nademanee, Auayporn P.;
    • Zelenetz, Andrew;
    • LaCasce, Ann S.;
    • Rodriguez, Maria Alma
    Publication type:
    Article
    10

    Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 13, p. 1993, doi. 10.1002/cncr.28676
    By:
    • Herrera, Alex F.;
    • Crosby‐Thompson, Allison;
    • Friedberg, Jonathan W.;
    • Abel, Gregory A.;
    • Czuczman, Myron S.;
    • Gordon, Leo I.;
    • Kaminski, Mark S.;
    • Millenson, Michael M.;
    • Nademanee, Auayporn P.;
    • Niland, Joyce C.;
    • Rodig, Scott J.;
    • Rodriguez, Maria A.;
    • Zelenetz, Andrew D.;
    • LaCasce, Ann S.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20<sup>+</sup> rituximab-sensitive/resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia (pre-B-ALL): potential targeted therapy in patients with poor risk CD20<sup>+</sup> BL and pre-B-ALL.

    Published in:
    British Journal of Haematology, 2015, v. 171, n. 5, p. 763, doi. 10.1111/bjh.13764
    By:
    • Awasthi, Aradhana;
    • Ayello, Janet;
    • Van de Ven, Carmella;
    • Elmacken, Mona;
    • Sabulski, Anthony;
    • Barth, Matthew J.;
    • Czuczman, Myron S.;
    • Islam, Humayun;
    • Klein, Christian;
    • Cairo, Mitchell S.
    Publication type:
    Article
    25
    26

    Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database.

    Published in:
    British Journal of Haematology, 2013, v. 163, n. 4, p. 487, doi. 10.1111/bjh.12570
    By:
    • Ban‐Hoefen, Makiko;
    • Vanderplas, Ann;
    • Crosby‐Thompson, Allison L.;
    • Abel, Gregory A.;
    • Czuczman, Myron S.;
    • Gordon, Leo I.;
    • Kaminski, Mark S.;
    • Kelly, Jennifer;
    • Millenson, Michael;
    • Nademanee, Auayporn P.;
    • Rodriguez, Maria A.;
    • Zelenetz, Andrew D.;
    • Niland, Joyce;
    • LaCasce, Ann S.;
    • Friedberg, Jonathan W.
    Publication type:
    Article
    27
    28
    29
    30
    31

    Biological effects and clinical significance of lenalidomide-induced tumour flare reaction in patients with chronic lymphocytic leukaemia: in vivo evidence of immune activation and antitumour response.

    Published in:
    British Journal of Haematology, 2011, v. 155, n. 4, p. 457, doi. 10.1111/j.1365-2141.2011.08882.x
    By:
    • Chanan-Khan, Asher A.;
    • Chitta, Kasyapa;
    • Ersing, Noreen;
    • Paulus, Aneel;
    • Masood, Aisha;
    • Sher, Taimur;
    • Swaika, Abhisek;
    • Wallace, Paul K.;
    • Mashtare, Terry L.;
    • Wilding, Greg;
    • Lee, Kelvin;
    • Czuczman, Myron S.;
    • Borrello, Ivan;
    • Bangia, Naveen
    Publication type:
    Article
    32
    33

    A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients.

    Published in:
    British Journal of Haematology, 2011, v. 154, n. 1, p. 104, doi. 10.1111/j.1365-2141.2011.08703.x
    By:
    • Sher, Taimur;
    • Ailawadhi, Sikander;
    • Miller, Kena C.;
    • Manfredi, Debbie;
    • Wood, Margaret;
    • Tan, Wei;
    • Wilding, Gregory;
    • Czuczman, Myron S.;
    • Hernandez-Ilizaliturri, Francisco J.;
    • Hong, Fredrick;
    • Sood, Raman;
    • Soniwala, Saif;
    • Lawrence, William;
    • Jamshed, Saad;
    • Masood, Aisha;
    • Iancu, Daniel;
    • Lee, Kelvin;
    • Chanan-Khan, Asher
    Publication type:
    Article
    34

    Distinct cellular and therapeutic effects of obatoclax in rituximab-sensitive and -resistant lymphomas.

    Published in:
    British Journal of Haematology, 2011, v. 153, n. 5, p. 599, doi. 10.1111/j.1365-2141.2011.08669.x
    By:
    • Brem, Elizabeth A.;
    • Thudium, Karen;
    • Khubchandani, Sapna;
    • Tsai, Ping-Chiao;
    • Olejniczak, Scott H.;
    • Bhat, Seema;
    • Riaz, Wasif;
    • Gu, Jenny;
    • Iqbal, Arshad;
    • Campagna, Ryan;
    • Knight, Joy;
    • Mavis, Cory;
    • Hoskin, Paul;
    • Deeb, George;
    • Gibbs, John F.;
    • Fetterly, Gerald;
    • Czuczman, Myron S.;
    • Hernandez-Ilizaliturri, Francisco J.
    Publication type:
    Article
    35

    Radioimmunotherapy of Non-Hodgkin's Lymphoma with <sup>90</sup>Y-DOTA Humanized Anti-CD22 IgG (<sup>90</sup>Y-Epratuzumab): Do Tumor Targeting and Dosimetry Predict Therapeutic Response?

    Published in:
    Journal of Nuclear Medicine, 2003, v. 44, n. 12, p. 2000
    By:
    • Sharkey, Robert M.;
    • Brenner, Arnold;
    • Burton, Jack;
    • Hajjar, George;
    • Toder, Stephen P.;
    • Alavi, Abass;
    • Matthies, Alexander;
    • Tsai, Donald E.;
    • Schuster, Stephen J.;
    • Stadtmauer, Edward A.;
    • Czuczman, Myron S.;
    • Lamonica, Dominick;
    • Kraeber-Bodere, Françoise;
    • Mahe, Beatrice;
    • Chatal, Jean-François;
    • Rogatko, André;
    • Mardirrosian, George;
    • Goldenberg, David M.
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    <sup>18</sup>F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 7, p. 2005, doi. 10.3109/10428194.2014.975800
    By:
    • Mylam, Karen Juul;
    • Kostakoglu, Lale;
    • Hutchings, Martin;
    • Coleman, Morton;
    • Lamonica, Dominick;
    • Czuczman, Myron S.;
    • Diehl, Louis F.;
    • Nielsen, Anne L.;
    • Jensen, Paw;
    • Loft, Annika;
    • Hendel, Helle W.;
    • Iyer, Victor;
    • Leppä, Sirpa;
    • Jyrkkiö, Sirkku;
    • Holte, Harald;
    • Eriksson, Mikael;
    • Gillstrøm, Dorte;
    • Hansen, Per B.;
    • Seppänen, Marko;
    • Hjorthaug, Karin
    Publication type:
    Article
    46

    Patterns of use of 18-fluoro-2-deoxy-D-glucose positron emission tomography for initial staging of grade 1-2 follicular lymphoma and its impact on initial treatment strategy in the National Comprehensive Cancer Network Non-Hodgkin Lymphoma Outcomes database

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 10, p. 2155, doi. 10.3109/10428194.2013.770151
    By:
    • Abou-Nassar, Karim E.;
    • Vanderplas, Ann;
    • Friedberg, Jonathan W.;
    • Abel, Gregory A.;
    • Niland, Joyce;
    • Rodriguez, Maria A.;
    • Czuczman, Myron S.;
    • Millenson, Michael;
    • Crosby, Allison;
    • Gordon, Leo I.;
    • Zelenetz, Andrew D.;
    • Kaminski, Mark;
    • Lacasce, Ann S.
    Publication type:
    Article
    47
    48
    49
    50

    Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial.

    Published in:
    Leukemia & Lymphoma, 2009, v. 50, n. 7, p. 1096, doi. 10.1080/10428190902912460
    By:
    • Chanan-Khan, Asher;
    • Miller, Kena C.;
    • Musial, Laurie;
    • Padmanabhan, Swaminathan;
    • Yu, Jihnhee;
    • Ailawadhi, Sikander;
    • Sher, Taimur;
    • Mohr, Alice;
    • Bernstein, Zale P.;
    • Barcos, Maurice;
    • Patel, Mehul;
    • Iancu, Dan;
    • Lee, Kelvin;
    • Czuczman, Myron S.
    Publication type:
    Article